This can look like staying at a lower dose of the drug for maintenance therapy or maintaining their regular dosage
BPC-157 has not received approval due to the absence of sufficient clinical studies confirming its health benefits in humans, according to the Food and Drug Administration (FDA)
A model-based meta-analysis of 24 antihyperglycemic drugs for type 2 diabetes: comparison of treatment effects at therapeutic doses
Initially, the dose is 0.25 mg one time a week
Novo Nordisk solved this problem for semaglutide (the active ingredient in Wegovy) by co-formulating it with an absorption enhancer called SNAC, which temporarily protects the drug in the stomach and helps it pass through the stomach lining
Hosseini, Salvage of sildenafil failures with bremelanotide: a randomized, double-blind, placebo controlled study, J